Attovia Stock
Attovia is creating a pipeline of biotherapeutics with an initial focus on immune-mediated disease and oncology. We leverage ATTOBODY, a novel biologics platform, to generate small format biparatopic binders that unlock the spatial aspect of target engagement.
Sign up for SecondMarket™ to view the market and buy or sell Attovia Stock
Buy + SellAttovia Funding
Sign up to gain insights into Attovia funding history, including the funding round, time period, and amount raised.
Sign Up to Unlock the DataDate | Financing Round | Amount | Price per share* | Valuation* |
---|---|---|---|---|
May 09, 2024 | Series B | 52.50M | ||
May 01, 2024 | Series B | 52.50M | ||
Jan 18, 2024 | Series A | 30.42M | ||
Jun 01, 2023 | Series A | 30.43M |
See Attovia Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Attovia Stock Valuation + Share Prices
View real-time Tape D™ data on Attovia stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket™ trading platform.
Get Started